Nanalysis Scientific Corp. NSCIF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.03M | -4.08M | -4.06M | -8.86M | -8.97M |
| Total Depreciation and Amortization | 1.27M | 1.39M | 1.83M | 487.50K | 1.12M |
| Total Amortization of Deferred Charges | 1.07M | 1.07M | 620.60K | 2.38M | 1.96M |
| Total Other Non-Cash Items | 1.70M | 1.38M | 1.39M | 6.58M | 7.14M |
| Change in Net Operating Assets | 1.09M | 687.10K | 2.62M | 677.80K | 8.60K |
| Cash from Operations | 2.10M | 447.80K | 2.41M | 1.27M | 1.26M |
| Capital Expenditure | -138.50K | -191.30K | -201.90K | -126.60K | -104.90K |
| Sale of Property, Plant, and Equipment | 39.70K | 86.70K | 75.50K | 131.90K | 149.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -581.80K | -894.00K | -1.14M | -1.11M | -1.19M |
| Cash from Investing | -680.60K | -998.60K | -1.27M | -1.10M | -1.14M |
| Total Debt Issued | -8.00K | 2.56M | 2.56M | 2.30M | 2.57M |
| Total Debt Repaid | -3.97M | -4.14M | -3.96M | -1.89M | -3.01M |
| Issuance of Common Stock | 2.91M | 3.25M | 2.48M | 389.00K | 389.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -20.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -726.00K | -906.00K | -963.00K | -939.00K | -963.00K |
| Cash from Financing | -1.31M | 538.20K | 149.90K | -28.20K | -684.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.90K | -12.50K | 1.29M | 143.10K | -566.90K |